Analysts said valuations have now turned favourable for long-term investors as the underlying strong positioning of Indian IT incumbents is undisputed in the global IT landscape, with strong execution capabilities and extensive range of offerings.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This